P-glycoprotein alters blood–brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy

References

• Elia M Amato C Bottitta M An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy Brain Dev 2012 34 10 873 876 22469695
   PubMed Web of Science ®Google Scholar
• Elia M Falco M Ferri R CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy Neurology 2008 23 71 13 997 999 18809835
   PubMed Web of Science ®Google Scholar
• Capovilla G Beccaria F Montagnini A Short-term nonhormonal and nonsteroid treatment in West syndrome Epilepsia 2003 44 8 1085 1088 12887441
   PubMed Web of Science ®Google Scholar
• Loscher W Potschka H Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases Prog Neurobiol 2005 76 1 22 76 16011870
   PubMed Web of Science ®Google Scholar
• Potschka H Loscher W Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain Neuroreport 2001 12 11 2387 2389 11496115
   PubMed Web of Science ®Google Scholar
• Tishler DM Weinberg KI Hinton DR Barbaro N Annett GM Raffel C MDR1 gene expression in brain of patients with medically intractable epilepsy Epilepsia 1995 36 1 1 6 8001500
   PubMed Web of Science ®Google Scholar
• Seegers U Potschka H Loscher W Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy Epilepsy Res 2002 51 3 257 268 12399076
   PubMed Web of Science ®Google Scholar
• Morimoto K Sato H Sato K Sato S Yamada N BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdale-kindling model of epilepsy Eur J Pharmacol 1997 339 1 11 15 9450611
   PubMed Web of Science ®Google Scholar
• Hung CC Chen CC Lin CJ Liou HH Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs Pharmacogenet Genomics 2008 18 5 390 402 18408562
   PubMed Web of Science ®Google Scholar
• Potschka H Fedrowitz M Loscher W P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of exrracellular levels of the major antiepileptic drug carmbamazepine in the brain Neuroreport 2001 12 6 3557 3560 11733711
   PubMed Web of Science ®Google Scholar
• Baltes S Gastens AM Fedrowitz M Potschka H Kaever V Löscher W Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein Neuropharmacology 2007 52 2 333 346 17045309
   PubMed Web of Science ®Google Scholar
• Morimoto K Goddard GV Seizure-triggering mechanism in the kindling model of epilepsy: I. EEG changes during stimulation from the site of stimulation Jpn J Psychiatry Neurol 1988 42 3 618 619 2853806
   PubMedGoogle Scholar
• Racine RJ Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalogr Clin Neurophysiol 1972 32 3 281 294 4110397
   PubMedGoogle Scholar
• Löscher W Rundfeldt C Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats J Pharmacol Exp Ther 1991 258 2 483 489 1650829
   PubMed Web of Science ®Google Scholar
• Sharom FJ ABC multidrug transporters: structure, function and role in chemoresistance Pharmacogenomics 2008 9 1 105 127 18154452
   PubMed Web of Science ®Google Scholar
• Polgar O Bates SE ABC transporters in the balance: is there a role in multidrug resistance? Biochem Soc Trans 2005 33 1 241 245 15667317
   PubMed Web of Science ®Google Scholar
• Choudhuri S Klaassen CD Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters Int J Toxicol 2006 25 4 231 259 16815813
   PubMed Web of Science ®Google Scholar
• Lee G Dallas S Hong M Bendayan R Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations Pharmacol Rev 2001 53 4 569 596 11734619
   PubMed Web of Science ®Google Scholar
• Shen S Zhang W ABC transporters and drug efflux at the blood-brain barrier Rev Neurosci 2010 21 1 29 53 20458886
   PubMed Web of Science ®Google Scholar
• Ohtsuki S Terasaki T Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development Pharm Res 2007 24 9 1745 1758 17619998
   PubMed Web of Science ®Google Scholar
• Loscher W Potschka H Blood-brain barrier active efflux transporters: ATP-binding cassette gene family NeuroRx 2005 2 1 86 98 15717060
   PubMedGoogle Scholar
• Elsinga PH Hendrikse NH Bart J Vaalburg W Waarde A PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS Curr Pharm Des 2004 10 13 1493 1503 15134571
   PubMed Web of Science ®Google Scholar
• Loscher W Potschka H Role of multidrug transporters in pharmaco-resistance to antiepileptic drugs J Pharmacol Exp Ther 2002 301 1 7 14 11907151
   PubMed Web of Science ®Google Scholar
• Sisodiya SM Lin WR Harding BN Squier MV Thom M Drug resistance in epilepsy: expression of drug resistance proteins in common cause of refractory epilepsy Brain 2002 125 1 22 31 11834590
   PubMed Web of Science ®Google Scholar
• Volk HA Potschka H Loscher W Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats Epilepsy Res 2004 58 1 67 79 15066676
   PubMed Web of Science ®Google Scholar
• Jeub M Beck H Siep E Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats Neuropharmacology 2002 42 1 107 116 11750920
   PubMed Web of Science ®Google Scholar
• Potschka H Loscher W In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats Epilepsia 2001 42 10 1231 1240 11737157
   PubMed Web of Science ®Google Scholar
• Lazarowski A Czornyj L Lubienieki F Girardi E Vazquez S D’Giano C ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy Epilepsia 2007 48 5 140 149 17910594
   PubMed Web of Science ®Google Scholar
• Rizzi M Caccia S Guiso Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance J Neurosci 2002 22 14 5833 5839 12122045
   PubMed Web of Science ®Google Scholar
• Iannetti P Spalice A Parisi P Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus Epilepsia 2005 46 6 967 969 15946342
   PubMed Web of Science ®Google Scholar
• Summers MA Moore JL McAuley JW Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy Ann Pharmacother 2004 38 10 1631 1634 15328394
   PubMed Web of Science ®Google Scholar
• Jambroszyk M Tipold A Potschka H Add-on treatment with verapamil in pharmacoresistant canine epilepsy Epilepsia 2011 52 2 284 291 21219313
   PubMed Web of Science ®Google Scholar
• Pirker S Baumgartner C Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil Eur J Neurol 2011 18 12 e151 22097953
   PubMed Web of Science ®Google Scholar
• Kerr BM Thummel KE Wurden CJ Human liver carbamazepine metabolism – role of CYP3A4 and CYP2C8 in 10,11-epoxide formation Biochem Pharmacol 1994 47 11 1969 1979 8010982
   PubMed Web of Science ®Google Scholar
• Kim RB Wandel C Leake B Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein Pharm Res 1999 16 3 408 414 10213372
   PubMed Web of Science ®Google Scholar
• Owen A Pirmohamed M Tettey JN Carbamazepine is not a substrate for P-glycoprotein Br J Clin Pharmacol 2001 51 4 345 349 11318771
   PubMed Web of Science ®Google Scholar
• Lu Y Yan Y Wang XF Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains Chin Med J 2004 117 11 1682 1686 15569486
   PubMed Web of Science ®Google Scholar
• Felix RA Barrand MA P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress J Neurochem 2002 80 1 64 72 11796744
   PubMed Web of Science ®Google Scholar
• Coppola G Auricchio G Federico R Carotenuto M Pascotto A Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study Epilepsia 2004 45 9 1049 1053 15329068
   PubMed Web of Science ®Google Scholar
• Coppola G Licciardi F Sciscio N Russo F Carotenuto M Pascotto A Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study Brain Dev 2004 26 1 26 29 14729411
   PubMed Web of Science ®Google Scholar
• Löscher W How to explain multidrug resistance in epilepsy? Epilepsy Curr 2005 5 3 107 112 16145617
   PubMedGoogle Scholar